Clinical characteristics | Cutoff | Sensitivity | Specificity | PPV | NPV | Accuracy | AUC | P | Point |
---|---|---|---|---|---|---|---|---|---|
Age | 68.5 | 0.16 | 0.98 | 0.83 | 0.66 | 0.67 | 0.57 | 0.281 | 2.00 |
FIGO stage | – | 0.10 | 0.89 | 0.33 | 0.62 | 0.59 | 0.49 | 0.888 | 1.00 |
Histology | – | 0.26 | 0.87 | 0.53 | 0.66 | 0.64 | 0.56 | 0.349 | 2.00 |
Tumor grade | – | 0.68 | 0.35 | 0.38 | 0.64 | 0.47 | 0.51 | 0.858 | 1.00 |
Preoperative serum CA125 level(U/ml) | 313.60 | 0.81 | 0.42 | 0.45 | 0.79 | 0.57 | 0.53 | 0.621 | 1.00 |
Preoperative serum HE4 level (pmol/L) | 777.10 | 0.48 | 0.89 | 0.71 | 0.74 | 0.73 | 0.68 | 0.007* | 2.00 |
ECOG performance status | 0 | 0.23 | 0.87 | 0.50 | 0.65 | 0.63 | 0.55 | 0.489 | 2 |
ASA | 3 | 0.07 | 0.94 | 0.40 | 0.63 | 0.61 | 0.50 | 0.959 | 1 |